HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Glu298Asp polymorphism in endothelial nitric oxide synthase gene is associated with coronary in-stent restenosis.

AbstractBACKGROUND:
Reduced or impaired synthesis of nitric oxide promotes the proliferation of vascular smooth muscle cells, and thus may induce the neointimal formation leading to coronary in-stent restenosis. Recent reports have suggested that the Glu298Asp polymorphism in exon 7 of the endothelial nitric oxide synthase gene is associated with coronary spasm and acute myocardial infarction. In this study, we have examined the implication of this polymorphism with regard to coronary restenosis after Palmaz-Schatz stent deployment.
METHODS:
Eighty-nine lesions in 85 consecutive patients were treated with Palmaz-Schatz stents, and were prospectively followed up for 6 months. The lesions were classified into a restenosis group (% diameter stenosis=50%) and a non-restenosis group. Assessment was made using an automated quantitative angiographic system. We performed polymerase chain reaction-restriction fragment length polymorphism analysis to detect the missense Glu298Asp variant in exon 7 of the endothelial nitric oxide synthase gene.
RESULTS:
Coronary risk factors and angiographic findings of stenotic lesions did not differ between the groups. Univariate analyses showed that the missense Glu298Asp variant was the only statistically significant predictor of restenosis (odds ratio, 4.27; P=0.025). In addition, multiple logistic regression analysis revealed the missense Glu298Asp variant as the only independent predictor for in-stent restenosis (odds ratio, 3.90; P=0.036).
CONCLUSIONS:
The missense Glu298Asp variant may be an independent risk factor for in-stent restenosis.
AuthorsTomomichi Suzuki, Kenji Okumura, Takahito Sone, Tai Kosokabe, Hideyuki Tsuboi, Junichiro Kondo, Hiroaki Mukawa, Hiroki Kamiya, Takahito Tomida, Hajime Imai, Hideo Matsui, Tetsuo Hayakawa
JournalInternational journal of cardiology (Int J Cardiol) Vol. 86 Issue 1 Pg. 71-6 (Nov 2002) ISSN: 0167-5273 [Print] Netherlands
PMID12243851 (Publication Type: Journal Article)
Chemical References
  • Aspartic Acid
  • Glutamic Acid
  • Nitric Oxide Synthase
Topics
  • Aged
  • Aged, 80 and over
  • Aspartic Acid (genetics)
  • Coronary Restenosis (genetics)
  • Endothelium, Vascular (enzymology)
  • Female
  • Genotype
  • Glutamic Acid (genetics)
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Mutation, Missense
  • Nitric Oxide Synthase (genetics)
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Polymorphism, Restriction Fragment Length
  • Stents (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: